Analyst consensus rating
Integra LifeSciences Holdings Analyst Rating: Hold
Direct answer
Integra LifeSciences Holdings's consensus rating is Hold.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $15.67.
Forecast evidence checked November 18, 2026.
Get free Integra LifeSciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.55
- Average price target
- $15.67
- High price target
- $23.00
- Low price target
- $13.00
- Low target gap
- -4.1%
- Target upside
- +15.6%
- High target gap
- +69.7%
- Target range width
- 73.8%
- Consensus rating
- Hold
- Analysts
- 9
- Evidence date
- November 18, 2026
- Valid through
- November 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Integra LifeSciences Holdings?
Integra LifeSciences Holdings has a verified Hold consensus. The same dataset has an average price target of $15.67.
How far are Integra LifeSciences Holdings's low and high targets from the recorded price?
The low target implies -4.1%, while the high target implies +69.7%.
How many analysts are included in Integra LifeSciences Holdings's consensus?
The verified consensus includes 9 analysts.
How is Integra LifeSciences Holdings's target upside or downside calculated?
The average target of $15.67 is divided by the recorded price of $13.55, then one is subtracted to produce +15.6%. This does not guarantee a future return.
When was Integra LifeSciences Holdings's analyst forecast verified?
The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.